Position in LLY
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$268,672
-$330,999 QoQ
Shares Held
224
-59.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
#4,242
of 4,605 holders
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Centennial Wealth Advisory LLC holds $4,264,920 across 8 Drug Manufacturers - General names. LLY ranks #5 (6.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PFE |
Pfizer Inc
|
47,757 | $1,149,988 | |
| 2 | JNJ |
Johnson & Johnson
|
3,173 | $805,846 | |
| 3 | AMGN |
Amgen Inc
|
2,160 | $782,179 | |
| 4 | ABBV |
AbbVie Inc.
|
2,331 | $586,572 | |
| 5 | LLY |
ELI LILLY & Co
This page
|
224 | $268,672 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
4,016 | $231,401 | |
| 7 | MRK |
Merck & Co., Inc.
|
1,798 | $231,043 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,656 | $209,219 |
All Filings in LLY
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $268,672 | 224 | Shares | Sole | 2026-07-13 | |
| 2025-12-31 | $599,671 | 558 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $279,258 | 366 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $272,055 | 349 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $262,639 | 318 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $230,828 | 299 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $266,667 | 301 | Shares | Sole | 2024-10-30 | |
| No filing history on record for this holder in this stock. | ||||||